Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
  • Bit Of A Blah Risk-Off Day- Except Regeneron (REGN) Up 14% 0 comments
    May 1, 2013 12:58 PM | about stocks: REGN

    Regeneron (NASDAQ:REGN) Up 30 Points On Allergan Delays For Vision Loss Drug

    As news came out from an Allergan (AGN $98.5) off 12%, conference call that their vision loss drug would be delayed, Regeneron shares soared 14%. Regeneron now has a market cap of $24B with a PE of 35.85 and a Price to Sales in the 16 range. 2013 Revenues are estimated at $1.9B.

    Regeneron was added to the Rayno Life Science Portfolio in March of 2009 at a Price of $17.50 and is the single biggest winner.

    In other action today many of our Life Science stocks were in the red with significant profit taking in: AMRI, ASTX, IMGN, PCYC, and SGEN. There appears to be significant distribution of stock today noting that many high flyers are down.

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

    Stocks: REGN
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.